Stock events for HCA Healthcare, Inc. (HCA)
Over the past six months, HCA Healthcare's stock has shown significant growth, with a 36.32% increase in the last six months and 7.69% in the past week as of November 28, 2025. Year-to-date, the stock has risen by 69.95%, and over the last year, it has seen a 55.33% increase. As of November 25, 2025, the share price was $515.85, representing a 56.82% increase from November 26, 2024. Key events impacting the stock include the Q3 2025 earnings report, which exceeded analysts' estimates, a quarterly dividend announcement of $0.72 per share, and increased yearly profit and revenue forecasts in October 2025.
Demand Seasonality affecting HCA Healthcare, Inc.’s stock price
HCA Healthcare has observed a return to normal volume seasonality in recent years, experiencing sustained demand for medical procedures, particularly non-urgent ones, since the second half of 2023. The company anticipates normal seasonality trends would lead to higher outpatient surgery volumes during the fourth quarter. Long-term, HCA expects 1-2% growth in inpatient volume and 2-3% in adjusted admissions. Demand in general is strong, although volumes can be limited by labor capacity. The company also noted strong emergency department (ED) volumes, up 11% year-over-year in Q4 2023.
Overview of HCA Healthcare, Inc.’s business
HCA Healthcare, Inc., founded in 1968 and headquartered in Nashville, Tennessee, is an American for-profit operator of healthcare facilities. It operates in the healthcare sector, focusing on hospitals and ambulatory surgery centers, providing a range of medical services through its network. The company offers hospital services such as general acute care, psychiatric, and rehabilitation care, including emergency care, surgery, diagnostic imaging, maternity care, ICUs, and oncology services. Ambulatory services include freestanding emergency rooms, surgery centers, urgent care clinics, and diagnostic centers. Physician services cover primary and specialty care, including cardiology, orthopedics, neurology, and telemedicine, with specialties in various diseases and conditions.
HCA’s Geographic footprint
HCA Healthcare operates across 20 states in the United States and in the United Kingdom. As of November 2025, there are 204 HCA Healthcare locations in the U.S., with Texas having the most (62 locations, 30%), followed by Florida (50 locations, 25%), and Tennessee (17 locations, 8%). As of December 2024, HCA Healthcare operated 248 hospitals across 19 states and the United Kingdom, making it the largest health system in the country by number of hospitals and net patient revenue.
HCA Corporate Image Assessment
In the past year, HCA Healthcare has received several notable recognitions for its brand reputation. It was named on Fortune's 2025 World's Most Admired Companies list, ranking first overall in its industry. HCA Healthcare was also recognized on Fortune's America's Most Innovative Companies List in 2025. For the 14th time, HCA Healthcare was recognized by Ethisphere in early 2024 for its commitment to business integrity. For the second consecutive year, HCA Healthcare was named a "Best Place to Work for Disability Inclusion" in 2023. In response to hurricanes Helene and Milton in 2024, HCA Healthcare deployed over 700 colleagues to disaster areas and contributed $1.5 million to community organizations for relief efforts.
Ownership
HCA Healthcare's ownership is a mix of institutional, insider, and retail investors, with institutional investors holding a significant portion of the company's shares, approximately 59.73% to 74.08%. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., Sanders Capital, LLC, State Street Corp (and State Street Global Advisors, Inc.), Capital World Investors (and Capital Research and Management Company), First Eagle Investment Management, LLC, Wellington Management Group Llp, Geode Capital Management, LLC, and UBS Asset Management AG. Significant individual owners (insiders) include Patricia F. Elcan, Thomas F. Frist Iii, William R. Frist, Thomas F. Frist Jr., and Patricia C. Frist.
Ask Our Expert AI Analyst
Price Chart
$484.77